Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Padmanee Sharma

Showing results (71-80 of 216) with videos related to

Pageof 22
Sort By:
Journal of Translational Medicine|June 15, 2022
Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge-December 1st-2nd, 2021Elizabeth M Burton, Rodabe N Amaria, Tina Cascone, et al.
Kidney International Reports|January 16, 2026
Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational EvidenceNada Youssef, Masroor Habeeb, Hong Chen, et al.
Cancer Research|May 20, 2016
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor RejectionTodd C Metzger, Hua Long, Shobha Potluri, et al.
The Oncologist|March 13, 2020
Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-AnalysisJad Chahoud, Pavlos Msaouel, Matthew T Campbell, et al.
American Journal of Clinical Oncology|June 19, 2012
Phase II trial of pemetrexed plus gemcitabine in patients with locally advanced and metastatic nonclear cell renal cell carcinomaStephen L Richey, Pheroze Tamboli, Chaan S Ng, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2007
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeXingxing Zang, R Houston Thompson, Hikmat A Al-Ahmadie, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinomaPadmanee Sharma, Yu Shen, Sijin Wen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2009
Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissuesHong Chen, Chrysoula I Liakou, Ashish Kamat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2017
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid MalignanciesIssa F Khouri, Irina Fernandez Curbelo, Francesco Turturro, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Spatial multi-omics and deep learning reveal fingerprints of immunotherapy response and resistance in hepatocellular carcinomaZhenqin Wu, Joseph Boen, Sonali Jindal, et al.
Pageof 22

Showing results (71-80 of 216) with videos related to

Sort By:
Pageof 22
Journal of Translational Medicine|June 15, 2022
Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge-December 1st-2nd, 2021Elizabeth M Burton, Rodabe N Amaria, Tina Cascone, et al.
Kidney International Reports|January 16, 2026
Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational EvidenceNada Youssef, Masroor Habeeb, Hong Chen, et al.
Cancer Research|May 20, 2016
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor RejectionTodd C Metzger, Hua Long, Shobha Potluri, et al.
The Oncologist|March 13, 2020
Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-AnalysisJad Chahoud, Pavlos Msaouel, Matthew T Campbell, et al.
American Journal of Clinical Oncology|June 19, 2012
Phase II trial of pemetrexed plus gemcitabine in patients with locally advanced and metastatic nonclear cell renal cell carcinomaStephen L Richey, Pheroze Tamboli, Chaan S Ng, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2007
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeXingxing Zang, R Houston Thompson, Hikmat A Al-Ahmadie, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinomaPadmanee Sharma, Yu Shen, Sijin Wen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2009
Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissuesHong Chen, Chrysoula I Liakou, Ashish Kamat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2017
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid MalignanciesIssa F Khouri, Irina Fernandez Curbelo, Francesco Turturro, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Spatial multi-omics and deep learning reveal fingerprints of immunotherapy response and resistance in hepatocellular carcinomaZhenqin Wu, Joseph Boen, Sonali Jindal, et al.
Pageof 22